Discovery of Infection Associated Metabolic Markers in Human African Trypanosomiasis

PLoS Neglected Tropical Diseases

Volumn 9, Issue 10, 2015, Pages

  Lamour, Sabrina D ^a   Gomez Romero, Maria ^a   Vorkas, Panagiotis A ^a   Alibu, Vincent P ^a   Saric, Jasmina ^a   Holmes, Elaine ^a   Sternberg, Jeremy M ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL ESTER; CREATININE; FORMIC ACID; GLYCOPROTEIN; HISTIDINE; LYSOPHOSPHATIDYLCHOLINE; N ACETYLATED GLYCOPROTEIN; PHENYLALANINE; PHOSPHATIDYLCHOLINE; POLYUNSATURATED PHOSPHATIDYLCHOLINE; SPHINGOMYELIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; AMINO ACID; LIPID;

AFRICAN TRYPANOSOMIASIS; ARTICLE; BLOOD SAMPLING; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNE RESPONSE; MASS SPECTROMETRY; METABOLISM; PRINCIPAL COMPONENT ANALYSIS; PROTON NUCLEAR MAGNETIC RESONANCE; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; ANIMAL; BLOOD; FEMALE; ISOLATION AND PURIFICATION; LIQUID CHROMATOGRAPHY; MALE; METABOLOME; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARASITOLOGY; PATHOLOGY; TRYPANOSOMA BRUCEI RHODESIENSE; TRYPANOSOMIASIS, AFRICAN; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; AMINO ACIDS; ANIMALS; BIOMARKERS; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; LIPIDS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MASS SPECTROMETRY; METABOLOME; TRYPANOSOMA BRUCEI RHODESIENSE; TRYPANOSOMIASIS, AFRICAN; YOUNG ADULT;

EID: 84959195210     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0004200     Document Type: Article

References (62)

1. Chappuis F, Loutan L, Simarro P, Lejon V, Buscher P, . (2005) Options for field diagnosis of human african trypanosomiasis. Clin Microbiol Rev18: 133–146. 15653823
2. Fèvre E,M., Wissmann Bv, Welburn SC, Lutumba P, . (2008) The burden of human african trypanosomiasis. PLoS Neglected Tropical Diseases2: e333. doi: 10.1371/journal.pntd.000033319104653
3. Sternberg JM, . (2004) Human african trypanosomiasis: Clinical presentation and immune response. Parasite Immunol26: 469–476. 15771682
4. Sternberg JM, Gierliński M, Biéler S, Ferguson MAJ, Ndung'u JM, . (2014) Evaluation of the diagnostic accuracy of prototype rapid tests for human african trypanosomiasis. PLoS Negl Trop Dis8: e3373. doi: 10.1371/journal.pntd.000337325521120
5. World Health Organization. (2012) Accelerating work to overcome the global impact of neglected tropical diseases: A roadmap for implementation.
6. Simarro PP, Franco JR, Diarra A, Ruiz Postigo JA, Jannin J, . (2013) Diversity of human african trypanosomiasis epidemiological settings requires fine-tuning control strategies to facilitate disease elimination. Res Rep Trop Med4: 1–6.
7. Lindon JC, Nicholson JK, Holmes E, Antti H, Bollard ME, et al. (2003) Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project. Toxicol Appl Pharmacol187: 137–146. 12662897
8. Teng R, Junankar PR, Bubb WA, Rae C, Mercier P, et al. (2009) Metabolite profiling of the intraerythrocytic malaria parasite plasmodium falciparum by 1H NMR spectroscopy. NMR Biomed22: 292–302. doi: 10.1002/nbm.132319021153
9. Lamour SD, Choi B, Keun H, Mueller I, Saric J, . (2012) Metabolic characterization of Leishmania major infection in activated and non-activated macrophages. J Proteome Res.
10. Vincent IM, Creek DJ, Burgess K, Woods DJ, Burchmore RJ, et al. (2012) Untargeted metabolomics reveals a lack of synergy between nifurtimox and eflornithine against trypanosoma brucei. PLoS Negl Trop Dis6: e1618. doi: 10.1371/journal.pntd.000161822563508
11. Wang Y, Utzinger J, Saric J, Li JV, Burckhardt J, et al. (2008) Global metabolic responses of mice to trypanosoma brucei brucei infection. Proc Natl Acad Sci U S A105: 6127–6132. doi: 10.1073/pnas.080177710518413599
12. Ghosh S, Sengupta A, Sharma S, Sonawat HM, . (2013) Metabolic perturbations of kidney and spleen in murine cerebral malaria: 1H NMR-based metabolomic study. PLoS ONE8: e73113. doi: 10.1371/journal.pone.007311324039868
13. Girones N, Carbajosa S, Guerrero NA, Poveda C, Chillon-Marinas C, et al. (2014) Global metabolomic profiling of acute myocarditis caused by trypanosoma cruzi infection. PLoS Negl Trop Dis8: e3337. doi: 10.1371/journal.pntd.000333725412247
14. Tritten L, Keiser J, Karwa T, Utzinger J, Holmes E, et al. (2014) Comparing systemic metabolic responses in mice to single or dual infection with plasmodium berghei and heligmosomoides bakeri. Mol BioSyst10: 2358–2367. doi: 10.1039/c4mb00097h24960299
15. Lamour SD, Veselkov KA, Posma JM, Giraud E, Rogers ME, et al. (2015) Metabolic, immune, and gut microbial signals mount a systems response to leishmania major infection. J Proteome Res14: 318–329. doi: 10.1021/pr500820225369177
16. Balog CIA, Meissner A, Göraler S, Bladergroen MR, Vennervald BJ, et al. (2011) Metabonomic investigation of human schistosoma mansoni infection. Mol BioSyst: 1742–206X.
17. Saric J, Li JV, Swann JR, Utzinger J, Calvert G, et al. (2010) Integrated cytokine and metabolic analysis of pathological responses to parasite exposure in rodents. J Proteome Res9: 2255–2264. doi: 10.1021/pr901019z20092362
18. Lejon V, Lardon J, Kenis G, Pinoges L, Legros D, et al. (2002) Interleukin (IL)-6, IL-8 and IL-10 in serum and CSF of trypanosoma brucei gambiense sleeping sickness patients before and after treatment. Transactions of The Royal Society of Tropical Medicine and Hygiene96: 329–333. 12174791
19. MacLean L, Chisi JE, Odiit M, Gibson WC, Ferris V, et al. (2004) Severity of human african trypanosomiasis in east africa is associated with geographic location, parasite genotype, and host inflammatory cytokine response profile. Infection and Immunity72: 7040–7044. 15557627
20. Dumas M, Maibaum EC, Teague C, Ueshima H, Zhou B, et al. (2006) Assessment of analytical reproducibility of 1H NMR spectroscopy based metabonomics for large-scale epidemiological research: The INTERMAP study. Anal Chem78: 2199–2208. 16579598
21. Rouzer CA, Cerami A, . (1980) Hypertriglyceridemia associated with trypanosoma brucei brucei infection in rabbits: Role of defective triglyceride removal. Mol Biochem Parasitol2: 31–38. 7464858
22. Nakamura Y, . (1998) Alterations of serum lipid, lipoprotein and inflammatory cytokine profiles of rabbits infected with trypanosoma brucei brucei. Vet Parasitol80: 117–125. 9870364
23. Gaithuma AK, Karanja SM, Ngotho M, Maathai RG, Kagira JM, et al. (2012) Lipid metabolism and other metabolic changes in vervet monkeys experimentally infected with trypanosoma brucei rhodesiense. J Med Primatol41: 75–81. doi: 10.1111/j.1600-0684.2011.00523.x22070162
24. MacLean LM, Odiit M, Chisi JE, Kennedy PGE, Sternberg JM, . (2010) Focus-specific clinical profiles in human african trypanosomiasis caused by Trypanosoma brucei rhodesiense. PLoS Negl Trop Dis4: e906. doi: 10.1371/journal.pntd.000090621151878
25. World Health Organization. (1998) Control and surveillance of african trypanosomiasis: Report of a WHO expert committee. WHO Technical Report Series.
26. Beckonert O, Keun HC, Ebbels TM, Bundy J, Holmes E, et al. (2007) Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc2: 2692–2703. 18007604
27. Veselkov KA, Lindon JC, Ebbels TM, Crockford D, Volynkin VV, et al. (2009) Recursive segment-wise peak alignment of biological (1)h NMR spectra for improved metabolic biomarker recovery. Anal Chem81: 56–66. doi: 10.1021/ac801154419049366
28. Dieterle F, Ross A, Schlotterbeck G, Senn H, . (2006) Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. application in 1H NMR metabonomics. Anal Chem78: 4281–4290. 16808434
29. Barton RH, Waterman D, Bonner FW, Holmes E, Clarke R, et al. (2010) The influence of EDTA and citrate anticoagulant addition to human plasma on information recovery from NMR-based metabolic profiling studies. Mol Biosyst6: 215–224. doi: 10.1039/b907021d20024083
30. Nicholson JK, Foxall PJD, Spraul M, Farrant RD, Lindon JC, . (1995) 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. Anal Chem67: 793–811. 7762816
31. Liu M, Tang H, Nicholson JK, Lindon JC, . (2002) Use of 1H NMR-determined diffusion coefficients to characterize lipoprotein fractions in human blood plasma. Magn Reson Chem40: S83–S88.
32. Sarafian MH, Gaudin M, Lewis MR, Martin F, Holmes E, et al. (2014) Objective set of criteria for optimization of sample preparation procedures for ultra-high throughput untargeted blood plasma lipid profiling by ultra performance liquid Chromatography–Mass spectrometry. Anal Chem86: 5766–5774. doi: 10.1021/ac500317c24820162
33. Isaac G, McDonald S, Astarita G, . (2011) Lipid separation using UPLC with charged surface hybrid technology. Waters App note.
34. Vorkas PA, Isaac G, Anwar MA, Davies AH, Want EJ, et al. (2015) Untargeted UPLC-MS profiling pipeline to expand tissue metabolome coverage: Application to cardiovascular disease. Anal Chem87: 4184–4193. doi: 10.1021/ac503775m25664760
35. Smith CA, Want EJ, O'Maille G, Abagyan R, Siuzdak G, . (2006) XCMS:Processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem78: 779–787. 16448051
36. Hotelling H, . (1933) Analysis of a complex of statistical variables into principal components. J Educ Psychol24: 417.
37. Bylesjö M, Rantalainen M, Cloarec O, Nicholson JK, Holmes E, et al. (2006) OPLS discriminant analysis: Combining the strengths of PLS-DA and SIMCA classification. J Chemometrics20: 341–351.
38. Benjamini Y, Hochberg Y, . (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society.Series B (Methodological)57: 289–300.
39. Vorkas PA, Shalhoub J, Isaac G, Want EJ, Nicholson JK, et al. (2015) Metabolic phenotyping of atherosclerotic plaques reveals latent associations between free cholesterol and ceramide metabolism in atherogenesis. J Proteome Res14: 1389–1399. doi: 10.1021/pr500989825565173
40. Wannemacher RW, Klainer AS, Dinterman RE, Beisel WR, . (1976) The significance and mechanism of an increased serum phenylalanine-tyrosine ratio during infection. The American Journal of Clinical Nutrition29: 997–1006. 822705
41. Nasstrom E, Vu Thieu NT, Dongol S, Karkey A, Voong Vinh P, et al. (2014) Salmonella typhi and salmonella paratyphi A elaborate distinct systemic metabolite signatures during enteric fever. Elife3: doi: 10.7554/eLife.03100
42. Lopansri BK, Anstey NM, Stoddard GJ, Mwaikambo ED, Boutlis CS, et al. (2006) Elevated plasma phenylalanine in severe malaria and implications for pathophysiology of neurological complications. Infect Immun74: 3355–3359. 16714564
43. Kaufman S, . (1989) An evaluation of the possible neurotoxicity of metabolites of phenylalanine. J Pediatr114: 895–900. 2654351
44. Enwonwu CO, Afolabi BM, Salako LO, Idigbe EO, Bashirelahi N, . (2000) Increased plasma levels of histidine and histamine in falciparum malaria: Relevance to severity of infection. J Neural Transm107: 1273–1287. 11145003
45. Watanabe M, Suliman ME, Qureshi AR, Garcia-Lopez E, Bárány P, et al. (2008) Consequences of low plasma histidine in chronic kidney disease patients: Associations with inflammation, oxidative stress, and mortality. The American Journal of Clinical Nutrition87: 1860–1866. 18541578
46. Niu YC, Feng RN, Hou Y, Li K, Kang Z, et al. (2012) Histidine and arginine are associated with inflammation and oxidative stress in obese women. Br J Nutr108: 57–61. doi: 10.1017/S000711451100528921996294
47. Brun R, Blum J, Chappuis F, Burri C, . (2010) Human african trypanosomiasis. The Lancet375: 148–159.
48. Omeje JN, Anene BM, . (2012) Comparative serum biochemical changes induced by experimental infection of T. brucei and T. congolense in pigs. Vet Parasitol190: 368–374. doi: 10.1016/j.vetpar.2012.07.00822858639
49. Bell JD, Brown JCC, Nicholson JK, Sadler PJ, . (1987) Assignment of resonances for ‘acute-phase’ glycoproteins in high resolution proton NMR spectra of human blood plasma. FEBS Lett215: 311–315. 2438159
50. Fischer K, Kettunen J, Würtz P, Haller T, Havulinna AS, et al. (2014) Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: An observational study of 17,345 persons. PLoS Med11: e1001606. doi: 10.1371/journal.pmed.100160624586121
51. Calder PC, . (2001) Polyunsaturated fatty acids, inflammation, and immunity. Lipids36: 1007–1024. 11724453
52. Visser BJ, Wieten RW, Nagel IM, Grobusch MP, . (2013) Serum lipids and lipoproteins in malaria-a systematic review and meta-analysis. Malaria J12: 1–16.
53. Khosla SN, Goyle N, Seth RK, . (1991) Lipid profile in enteric fever. J Assoc Physicians India39: 260–262. 1880095
54. Alvarez C, Ramos A, . (1986) Lipids, lipoproteins, and apoproteins in serum during infection. Clin Chem32: 142–145. 3940695
55. Soares NM, Leal TF, Fiuza MC, Reis EA, Souza MA, et al. (2010) Plasma lipoproteins in visceral leishmaniasis and their effect on leishmania-infected macrophages. Parasite Immunol32: 259–266. doi: 10.1111/j.1365-3024.2009.01187.x20398226
56. Black S, Vandeweerd V, . (1989) Serum lipoproteins are required for multiplication of trypanosoma brucei brucei under axenic culture conditions. Mol Biochem Parasitol37: 65–72. 2615788
57. Coppens I, Levade T, Courtoy PJ, . (1995) Host plasma low density lipoprotein particles as an essential source of lipids for the bloodstream forms of trypanosoma brucei. J Biol Chem270: 5736–5741. 7890701
58. Richmond GS, Gibellini F, Young SA, Major L, Denton H, et al. (2010) Lipidomic analysis of bloodstream and procyclic form trypanosoma brucei. Parasitology137: 1357–1392. doi: 10.1017/S003118201000071520602846
59. Dixon H, Williamson J, . (1970) The lipid composition of blood and culture forms of trypanosoma lewisi and trypanosoma rhodesiense compared with that of their environment. Comp Biochem Physiol33: 111–128. 5440923
60. Smith TK, Bütikofer P, . (2010) Lipid metabolism in trypanosoma brucei. Mol Biochem Parasitol172: 66–79. doi: 10.1016/j.molbiopara.2010.04.00120382188
61. Maceyka M, Spiegel S, . (2014) Sphingolipid metabolites in inflammatory disease. Nature510: 58–67. doi: 10.1038/nature1347524899305
62. Huet G, Lemesre JL, Grard G, Noireau F, Boutignon F, et al. (1990) Serum lipid and lipoprotein abnormalities in human african trypanosomiasis. Trans R Soc Trop Med Hyg84: 792–794. 2096509